Headaches are a common symptom of a stressful lifestyle, your body not feeling well and other issues. While headaches can be dealt with easily, migraines are not so easy to handle. Migraines are a type of headache that feels like severe throbbing and pulsing sensation, almost like you are hearing your own heartbeat in your brain, usually on one side of the brain. Many people believe that migraines are not that big of a deal because you just have to deal with the pain, but that is not all migraine is, some people find it very difficult to do their daily tasks as they experience dizzying spells, nausea and extreme sensitivity to light and sound! These attacks can last hours and make it difficult for people to go about their daily lives as well. While there are medications available for migraine patients, these medications need time to take effect, so you may be in a lot of pain, but there are not many quick reliefs you can have in place other than learning the symptoms of a migraine attack and taking medication before it happens. But a new approval by the FDA may change this!

The U.S. Food and Drug Administration (FDA) has approved Symbravo, a new medicine to treat acute migraine attacks in adults. This means adults can now use Symbravo to get relief from their migraine symptoms. The FDA's decision was based on the results of three big studies, called Phase 3 trials. These trials involved over 21,000 migraine attacks, so the FDA has a lot of information about how well Symbravo works and how safe it is. The FDA only approves medicines that have been shown to be both safe and effective through a thorough testing process.

Importance of New Treatment Option

"Migraine attacks can happen suddenly and really mess up people's lives. It's estimated that over 39 million people in the U.S. alone get migraines," said Herriot Tabuteau, M.D., CEO of Axsome Therapeutics told US News. This shows how common migraines are and how important it is to have good treatments. "Symbravo gives patients and doctors a new option that can quickly stop a migraine attack, keep it away, and let people get back to their normal activities, all with just one dose." Having a medicine that can give fast and long-lasting relief from migraine pain is a big deal for millions of people. This new treatment is a real step forward in how we treat migraines.

Symbravo Trial Results, How Was It Approved

The trials took place in 3 steps, the Momentum trial study focused on people whose migraines had moderate to severe pain. The results showed that a lot more people taking Symbravo felt pain-free two hours after taking the medicine compared to those who took a placebo which is a dummy pill. Even better, many people felt relief for up to 24 and even 48 hours after just one dose. This long-lasting relief is really important for people with migraines because it means they can get back to their normal lives without worrying about the pain coming back. The study also looked at how many people were free from their worst symptom, like sensitivity to light or sound, or nausea. Symbravo worked better than the placebo in this area too.

While the intercept trial looked at people who took Symbravo when their migraine pain was still mild. Even when the pain was just starting, Symbravo was effective. The results were similar to the MOMENTUM trial, with many people getting pain relief and relief from their worst symptoms. Treating migraines early is often better because it can stop the pain from getting really bad.

And lastly the Movement trial which was to see how safe the medication is when people take it regularly. This study followed 706 people who had at least two migraines a month. The most common side effects people experienced were sleepiness and dizziness. While these side effects are important to know about, the study showed that Symbravo is generally safe for people to use on a regular basis.

India's flagship health insurance scheme, Ayushman Bharat-Pradhan Mantri Jan Arogya Yojana (AB PM-JAY), which covers more than 62 crore people, could soon offer higher financial protection if a key parliamentary recommendation is accepted.

A Parliamentary Standing Committee on Health and Family Welfare has recommended increasing the insurance cover under PM-JAY from the current Rs 5 lakh to Rs 10 lakh, according to a report by The Times of India.

The committee said the existing coverage is inadequate to meet the cost of several life-saving treatments, including liver transplants, complex cardiac surgeries, and immunotherapy.

Key recommendations

The panel has proposed:

• Increasing PM-JAY health insurance coverage from ₹5 lakh to ₹10 lakh.
• Introducing special high-cost treatment packages for expensive procedures.
• Adopting a differential pricing model for complex and advanced medical interventions.
Supporting higher coverage through:

• Pooled financing
• Negotiated pricing with hospitals and medical device manufacturers
• Co-funding mechanisms with states.

Recommendations To Improve Cashless Treatment

To improve the efficiency of the scheme, the committee also recommended:

• Strict enforcement of the six-hour turnaround time for pre-authorization of cashless treatment.
• Imposing penalties on hospitals or agencies responsible for unnecessary delays.
• Conducting regular audits of pre-authorization workflows.
• Expanding auto-approval for more low-risk procedures.
• Deploying AI-enabled case tracking to speed up approvals and improve transparency.

What is Ayushman Bharat PM-JAY?

Launched in September 2018, Ayushman Bharat-Pradhan Mantri Jan Arogya Yojana (AB PM-JAY) is the world's largest government-funded health assurance program.

The scheme currently provides Rs 5 lakh per family per year for secondary and tertiary care hospitalization, covering around 12 crore families, representing the bottom 40 per cent of India's population.

It was later expanded to include around 6 crore senior citizens aged 70 years and above from 4.5 crore families, irrespective of their socio-economic status. The scheme also covers poor and vulnerable families, as well as gig and platform workers.

Recent milestones

Last month, West Bengal became the 36th state to implement the Centre's flagship health insurance scheme.

Union Health Minister J.P. Nadda recently said one of the government's biggest achievements has been reducing out-of-pocket healthcare expenditure, which has fallen from 64.6 per cent before 2018 to 43.4 per cent. He added that AB PM-JAY has enabled timely access to quality healthcare through a cashless, paperless, and fully digital platform.

According to the government, the scheme has achieved the following milestones:

• More than 44 crore Ayushman Cards have been created.
• Over 12 crore hospital admissions have been authorized under the scheme.
• Women account for nearly half of all beneficiaries.
• More than 104 crore health records have been linked to over 93 crore ABHA accounts.

Universal health coverage by 2033

In March, Finance Minister Nirmala Sitharaman told Parliament that the government aims to achieve universal health coverage by 2033.

Addressing the Rajya Sabha, she said health insurance has become a priority area for the government, with the sector covering 58 crore lives during 2024-25, according to news agency PTI.

"Health insurance is a priority for this government. In fact, we are hoping that by 2033 we will have insurance cover for all," Sitharaman said.

A diarrheal illness caused by the parasite Cyclospora cayetanensis is spreading across multiple US states, with federal health officials reporting a higher-than-expected number of cyclosporiasis cases this summer. While several outbreaks have been identified, investigators have yet to pinpoint a common source.

The US Centers for Disease Control and Prevention (CDC) is investigating clusters of infections in Illinois, New York, Pennsylvania, Texas, Michigan, Ohio, Alabama, Kentucky, Tennessee, Virginia and West Virginia. Some clusters have been linked to Mexican-style restaurants, a grocery chain and a catered event, but officials say there is no evidence yet that they are part of a single nationwide outbreak, CNN reported.

Meanwhile, the US Food and Drug Administration (FDA) is tracing fresh produce, including white and green onions, cucumbers and cilantro, as potential sources of contamination.

Michigan has reported the largest outbreak so far. As of July 6, the state had confirmed 678 cases of cyclosporiasis, according to the Michigan Department of Health and Human Services (MDHHS). The state typically records around 50 cases annually, making this year's outbreak more than 13 times higher than normal.

Ohio has also seen a sharp rise, reporting 177 cases as of July 2. Nearly 171 of those infections were recorded after June 20, with cases confirmed across 43 counties.

Nationally, excluding Michigan, the CDC reported 145 confirmed cases across 17 states between May 1 and June 16. At least 20 people have been hospitalized, though no deaths have been reported. Patients ranged in age from 5 to 86 years, with a median age of 42, and about 61% of cases were reported in women.

Why Is It So Difficult To Find The Source?

Experts say Cyclospora cayetanensis is much harder to trace than common foodborne bacteria such as E. coli and Salmonella.

Investigators often rely on DNA fingerprinting to connect bacterial infections to contaminated food through laboratory networks such as PulseNet. However, this approach is far less effective for Cyclospora because the parasite has a far more complex genetic makeup, making it difficult to link cases to a single food item or supplier.

Dr. Max Teplitski, former head of the Division of Food Safety at the US Department of Agriculture and now chief science officer at the International Fresh Produce Association, said the parasite remains one of the most difficult foodborne pathogens to investigate, contributing to delays in identifying the outbreak source, CNN reported.

How To Prevent Cyclospora Infection

The CDC recommends the following precautions to reduce the risk of infection:

• Wash your hands thoroughly with soap and water before and after handling fresh produce.
• Rinse fruits and vegetables under running water before eating, cutting or cooking them.
• Do not rewash produce labeled "prewashed."
• Scrub firm produce, such as melons and cucumbers, with a clean produce brush.
• Cut away bruised or damaged portions before eating.
• Refrigerate cut, peeled or cooked fruits and vegetables within two hours.

Cyclospora spreads through food or water contaminated with human feces and is not transmitted directly from person to person.

Dr. Darien Sutton, an emergency medicine physician and ABC News medical correspondent, stressed that proper handwashing is essential because alcohol-based hand sanitizers are not effective against the parasite.

"This type of parasite doesn't easily go away with alcohol-based hand sanitizer. So, good old handwashing is really key here," Sutton said.

The US Food and Drug Administration (FDA) has announced a recall of organic frozen blueberries sold at Publix stores across eight US states after they were linked to a potential outbreak of E. coli infections.

GreenWise Organic IQF Blueberries were first recalled by Frutas y Hortalizas del Sur S.A. of San Carlos, Chile, which supplied the product to grocery chain Publix. Publix then recalled the frozen blueberries from its stores on July 3, 2026, according to a company statement.

According to FDA, the outbreak has resulted in 12 confirmed cases of E. coli-related gastrointestinal illness, including four hospitalizations. The FDA also said it has received reports of illness after consumers ate the frozen blueberries.

While many strains of E. coli are harmless, the bacteria involved in this recall is Shiga toxin-producing E. coli (STEC).

"E. coli O145 is a Shiga toxin-producing E. coli (STEC) that can cause illness characterised by severe stomach cramps, diarrhoea (which may be bloody), and vomiting," the FDA said.

The agency added that although most healthy people recover within a week, some infections can lead to hemolytic uremic syndrome (HUS), a serious complication that can cause kidney damage, particularly in young children, older adults, and people with weakened immune systems.

Which States Are Affected?

Also read: Why Fentanyl Addiction Treatments Are Losing Effectiveness, Study Finds

The recalled blueberries were distributed to Publix stores in:

• Alabama
• Florida
• Georgia
• Kentucky
• North Carolina
• South Carolina
• Tennessee
• Virginia

Which Blueberries Are Being Recalled?

The FDA advises consumers to check their freezers for the following product:

• Product: Frozen GreenWise Organic IQF Blueberries
• Package Size: 10 oz
• Lot Code: 60401
• Best By Date: February 9, 2028

Consumers who have the affected product should not eat it. Frutas y Hortalizas del Sur S.A. said it is working closely with regulatory authorities and customers. The company has instructed all customers who received the affected lot to immediately isolate the product, stop distributing it, and notify any downstream customers.

What Is E. coli?

Escherichia coli (E. coli) is a group of bacteria that normally lives in the intestines of humans and animals. Most strains are harmless and help with digestion. However, certain strains produce toxins that can cause serious illness when ingested through contaminated food or water.

What Happens During an E. coli Infection?

An E. coli infection most commonly affects the digestive system, causing:

• Watery diarrhoea
• Severe abdominal cramps
• Gastroenteritis
• Vomiting
• Mild fever
• Loss of appetite

Some infections, particularly those caused by Shiga toxin-producing E. coli, can lead to hemolytic uremic syndrome (HUS), a potentially life-threatening condition that damages the kidneys.

How to Protect Yourself From E. coli

You can reduce your risk of E. coli infection by:

• Washing your hands thoroughly with soap and water.
• Handling raw and cooked foods separately.
• Cooking food, especially meat, thoroughly.
• Washing fruits and vegetables before eating.
• Drinking safe, clean water and avoiding unpasteurised products.